These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31677214)

  • 1. Trends in utilization of deceased donor kidneys based on hepatitis C virus status and impact of public health service labeling on discard.
    Ariyamuthu VK; Sandikci B; AbdulRahim N; Hwang C; MacConmara MP; Parasuraman R; Atis A; Tanriover B
    Transpl Infect Dis; 2020 Feb; 22(1):e13204. PubMed ID: 31677214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States.
    Chang SH; Merzkani M; Lentine KL; Wang M; Axelrod DA; Anwar S; Schnitzler MA; Wellen J; Chapman WC; Alhamad T
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):251-261. PubMed ID: 33451990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
    Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
    Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Pruett TL; Clark MA; Taranto SE
    Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.
    de Vera ME; Volk ML; Ncube Z; Blais S; Robinson M; Allen N; Evans R; Weissman J; Baron P; Kore A; Bratton C; Garnett G; Hoang T; Wai P; Villicana R
    Am J Transplant; 2018 Oct; 18(10):2451-2456. PubMed ID: 30040178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Listing practices and graft utilization of hepatitis C-positive deceased donors in liver and kidney transplant.
    Kling CE; Perkins JD; Biggins SW; Johnson CK; Limaye AP; Sibulesky L
    Surgery; 2019 Jul; 166(1):102-108. PubMed ID: 31072671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race, Education, and Gender Disparities in Transplantation of Kidneys From Hepatitis C Viremic Donors.
    Nguyen T; Sise ME; Delgado C; Williams W; Reese P; Goldberg D
    Transplantation; 2021 Aug; 105(8):1850-1857. PubMed ID: 33141804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.
    Sibulesky L; Kling CE; Blosser C; Johnson CK; Limaye AP; Bakthavatsalam R; Leca N; Perkins JD
    Am J Transplant; 2018 Oct; 18(10):2465-2472. PubMed ID: 29451354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization rates and clinical outcomes of hepatitis C positive donor hearts in the contemporary era.
    Madan S; Patel SR; Rahgozar K; Saeed O; Murthy S; Vukelic S; Sims DB; Shin JJ; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2019 Sep; 38(9):907-917. PubMed ID: 31495408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year.
    Volk ML; Wilk AR; Wolfe C; Kaul DR
    Transplantation; 2017 Jul; 101(7):1666-1669. PubMed ID: 28196048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
    Cannon RM; Locke JE; Orandi BJ; Anderson DJ; Davis EG; Mackelaite L; Dave H; Eng M; Jones CM
    Transplantation; 2020 Jun; 104(6):1215-1228. PubMed ID: 31517783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
    Czarnecka P; Czarnecka K; Tronina O; Baczkowska T; Durlik M
    Ren Fail; 2022 Dec; 44(1):434-449. PubMed ID: 35260039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Kidney Discard from Expanded Criteria Donors Undergoing Donation after Circulatory Death.
    Singh SK; Kim SJ
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):317-23. PubMed ID: 26668028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes for potential kidney transplant recipients offered public health service increased risk kidneys: A single-center experience.
    Fernandez HE; Chiles MC; Pereira M; Husain SA; Miko B; Baral P; Dale LA; Patel S; Runge B; Tsapepas D; Sandoval PR; Ratner LE; Cohen DJ; Mohan S
    Clin Transplant; 2018 Dec; 32(12):e13427. PubMed ID: 30329179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deceased organ donor screening for human immunodeficiency virus, hepatitis B virus and hepatitis C virus: Discordant serology and nucleic acid testing results.
    Theodoropoulos N; Nowicki MJ; Chinchilla-Reyes C; Dionne S; Jaramillo A; Mone T; Hasz R; Jendrisak MD; Ladner DP; Ison MG
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29178242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys.
    Potluri VS; Goldberg DS; Mohan S; Bloom RD; Sawinski D; Abt PL; Blumberg EA; Parikh CR; Sharpe J; Reddy KR; Molnar MZ; Sise M; Reese PP
    J Am Soc Nephrol; 2019 Oct; 30(10):1939-1951. PubMed ID: 31515244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients.
    Luckett K; Kaiser TE; Bari K; Safdar K; Schoech MR; Apewokin S; Diwan TS; Cuffy MC; Anwar N; Shah SA
    J Am Coll Surg; 2019 Apr; 228(4):560-567. PubMed ID: 30586641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors leading to the discard of deceased donor kidneys in the United States.
    Mohan S; Chiles MC; Patzer RE; Pastan SO; Husain SA; Carpenter DJ; Dube GK; Crew RJ; Ratner LE; Cohen DJ
    Kidney Int; 2018 Jul; 94(1):187-198. PubMed ID: 29735310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Deceased Donor Kidney Discard in the United States.
    Marrero WJ; Naik AS; Friedewald JJ; Xu Y; Hutton DW; Lavieri MS; Parikh ND
    Transplantation; 2017 Jul; 101(7):1690-1697. PubMed ID: 27163541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.